OC
ARTC

Oppenheimer & Co’s ARTHROCARE CORP ARTC Stock Holding History

Oppenheimer & Co’s Portfolio ARTC Stock Details ARTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-9,173
Closed -$317K – 1421
2013
Q2 		$317K Buy
+9,173
New +$315K 0.01% 906

Other funds holding ARTC

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Oppenheimer & Co's ARTC Position: Q3 2013 in Review

Oppenheimer & Co sold out of ARTHROCARE CORP (ARTC) in Q3 2013, closing a stake of 9,173 shares — an estimated $317K sold.

Oppenheimer & Co first reported a position in ARTC in Q2 2013 and held it in 1 quarter. The position peaked at $317K in Q2 2013. 118 funds tracked by Wall St. Rank hold ARTC as of Q3 2013.

  • Oppenheimer & Co reported no remaining ARTHROCARE CORP position as of Q3 2013 after selling out during the quarter.
  • Oppenheimer & Co sold 9,173 ARTHROCARE CORP shares in Q3 2013, an estimated $317K.
  • Oppenheimer & Co first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 1 quarter.
  • Oppenheimer & Co's ARTHROCARE CORP position peaked at $317K in Q2 2013.
  • 118 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q3 2013.

Based on Oppenheimer & Co's 13F filing for Q3 2013, filed 1 Nov 2013.